Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?
<sup>68</sup>Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions; Trial registration number: NCT06247566; Date of registration: 2021-11-01; URL of trial registry record: https://clinicaltrials.gov/study/NCT06247566 .
Authors
- Zixin Shu (ORCID: https://orcid.org/0000-0001-6078-5645)
- Tingting Long (ORCID: https://orcid.org/0009-0008-1745-3280)
- Yi Yang (ORCID: https://orcid.org/0000-0002-3511-9197)
- Xiaodan Fu (ORCID: https://orcid.org/0000-0001-6969-7369)
- Kai Cheng (ORCID: https://orcid.org/0009-0009-3914-4144)
- Tiejian Jiang (ORCID: https://orcid.org/0009-0004-3580-1200)
- Bo Zhang (ORCID: https://orcid.org/0000-0001-9780-9049)
- Min Guo (ORCID: https://orcid.org/0000-0003-4945-5877)
- Bingsheng Li (ORCID: https://orcid.org/0000-0002-1022-1611)
- Jiaxian Chen (ORCID: https://orcid.org/0000-0002-6592-5173)
- Longfei Liu (ORCID: https://orcid.org/0000-0003-0274-4057)
- Xiang Chen (ORCID: https://orcid.org/0000-0002-4504-8732)
- Yu Gan (ORCID: https://orcid.org/0000-0001-9540-6158)
- Zhuying Xia
- Yao He
Institutions
- Central South University (CN)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1186/s13550-025-01309-4
- Citations
- 3
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province